$ Value
$3K
Shares
5,462
Price
$1
Filed
Nov 24
Insider
Name
Cowan Chad
Title
Chief Scientific Officer
CIK
0002039294
Roles
Transaction Details
Transaction Date
2025-11-20
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
987,027
Footnotes
The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. | Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Filing Info
Cowan Chad's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | IPSC | F | $3K |
| 2026-03-11 | IPSC | F | $4K |
| 2026-02-02 | IPSC | A | $0 |
| 2026-02-02 | IPSC | A | $0 |
| 2026-01-02 | IPSC | F | $2K |
| 2025-12-22 | IPSC | ▲ | $49K ★ |
| 2025-11-20 | IPSC | ▼ | $3K |
| 2025-09-18 | IPSC | A | $0 |
Other Insiders at IPSC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Carr Douglas
SVP Finance & Operations
|
— | $19K | 2026-03-12 |
|
Russotti Gregory
See Remarks
|
— | $27K | 2026-03-12 |
|
Pfeiffenberger Brent
President and CEO
|
— | — | 2026-03-11 |
|
Cowan Chad
Chief Scientific Officer
|
— | — | 2026-04-01 |
| Murphy Martin Patrick | — | — | 2025-12-09 |